| Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study JL Pablos, M Galindo, L Carmona, A Lledó, M Retuerto, R Blanco, ... Annals of the rheumatic diseases 79 (12), 1544-1549, 2020 | 243 | 2020 |
| Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases JL Pablos, L Abasolo, JM Alvaro-Gracia, FJ Blanco, R Blanco, I Castrejón, ... Annals of the rheumatic diseases 79 (9), 1170-1173, 2020 | 167 | 2020 |
| Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care I Castrejón, C Tani, M Jolly, A Huang, M Mosca Clin Exp Rheumatol 32 (5 Suppl 85), 85-95, 2014 | 125 | 2014 |
| Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes F Montero, J Martínez-Barrio, B Serrano-Benavente, T González, J Rivera, ... Rheumatology international 40 (10), 1593-1598, 2020 | 111 | 2020 |
| Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research … P Machado, I Castrejon, W Katchamart, R Koevoets, B Kuriya, M Schoels, ... Annals of the rheumatic diseases 70 (1), 15-24, 2011 | 102 | 2011 |
| MDHAQ/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as … I Castrejón, MJ Bergman, T Pincus JCR: Journal of Clinical Rheumatology 19 (4), 169-174, 2013 | 75 | 2013 |
| Importance of patient history and physical examination in rheumatoid arthritis compared to other chronic diseases: results of a physician survey I Castrejón, L McCollum, MD Tanriover, T Pincus Arthritis care & research 64 (8), 1250-1255, 2012 | 74 | 2012 |
| Update on methotrexate as the anchor drug for rheumatoid arthritis. T Pincus, KA Gibson, I Castrejón Bulletin of the Hospital for Joint Diseases 71, 2013 | 73 | 2013 |
| Diagnosis of fibromyalgia: Disagreement between fibromyalgia criteria and clinician‐based fibromyalgia diagnosis in a university clinic F Wolfe, J Schmukler, S Jamal, I Castrejon, KA Gibson, S Srinivasan, ... Arthritis care & research 71 (3), 343-351, 2019 | 64 | 2019 |
| Evidence that the Strategy is More Important than the Agent to Treat Rheumatoid Arthritis. T Pincus, I Castrejón Bulletin of the Hospital for Joint Diseases 71, 2013 | 64 | 2013 |
| Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis I Castrejon, E Toledano, MP Rosario, E Loza, F Pérez-Ruiz, L Carmona Rheumatology international 35, 1127-1137, 2015 | 53 | 2015 |
| A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass M Ibañez, AM Ortiz, I Castrejón, JA García-Vadillo, I Carvajal, ... Arthritis research & therapy 12, 1-9, 2010 | 51 | 2010 |
| Measures of adult systemic lupus erythematosus: disease activity and damage S Arora, DA Isenberg, I Castrejon Arthritis Care & Research 72, 27-46, 2020 | 49 | 2020 |
| Decline of mean initial prednisone dosage from 10.3 to 3.6 mg/day to treat rheumatoid arthritis between 1980 and 2004 in one clinical setting, with long‐term effectiveness of … T Pincus, T Sokka, I Castrejón, M Cutolo Arthritis care & research 65 (5), 729-736, 2013 | 49 | 2013 |
| Patient self-report outcomes to guide a treat-to-target strategy in clinical trials and usual clinical care of rheumatoid arthritis I Castrejón, T Pincus Clinical and Experimental Rheumatology-Incl Supplements 30 (4), S50, 2012 | 48 | 2012 |
| Treat-to-target: not as simple as it appears T Pincus, I Castrejón, M Bergman, Y Yazici Clinical and Experimental Rheumatology-Incl Supplements 30 (4), S10, 2012 | 47 | 2012 |
| Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician … AD Askanase, I Castrejón, T Pincus The Journal of Rheumatology 38 (7), 1309-1316, 2011 | 44 | 2011 |
| Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease T Pincus, I Castrejon, Y Yazici, KA Gibson, MJ Bergman, JA Block Clin Exp Rheumatol 37 (5), 7-17, 2019 | 43 | 2019 |
| Disease burden in osteoarthritis is similar to that of rheumatoid arthritis at initial rheumatology visit and significantly greater six months later JR Chua, S Jamal, M Riad, I Castrejon, AM Malfait, JA Block, T Pincus Arthritis & Rheumatology 71 (8), 1276-1284, 2019 | 43 | 2019 |
| Prediction of remission in a French early arthritis cohort by RAPID3 and other core data set measures, but not by the absence of rheumatoid factor, anticitrullinated protein … I Castrejón, M Dougados, B Combe, B Fautrel, F Guillemin, T Pincus The Journal of rheumatology 43 (7), 1285-1291, 2016 | 43 | 2016 |
theodore pincusprofessor of medicineEmail verificata su rush.edu
